Talphera (TLPH) Cash from Operations (2010 - 2026)
Talphera's (TLPH) quarterly Cash from Operations came in at 3400000.0 in Q1 2026, up 2.02% year-on-year from 3332768.36 in Q1 2025, and down 39.57% quarter-over-quarter from 2436000.0 in Q4 2025.
Talphera (TLPH) Cash from Operations (2010 - 2026) Analysis & Trends
Talphera's Cash from Operations history runs 17 years deep, the most recent figure standing at 3400000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 2.02% year-over-year to 3400000.0 in Q1 2026; TTM through Mar 2026 was 11294000.0, a 14.89% increase from a year earlier, with the FY2025 full-year figure at 11364000.0, up 10.4% from the prior year.
- Cash from Operations retreated to 3400000.0 in Q1 2026 per TLPH's latest filing, from 2436000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2254000.0 in Q4 2024 and bottomed at 8934000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 3470000.0 (2025), against an average of 4310000.0.
- Across the five-year window, Cash from Operations tumbled 32.84% in 2022 and jumped 45.09% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 5413000.0 in 2022, then gained by 27.05% to 3949000.0 in 2023, then surged by 42.92% to 2254000.0 in 2024, then slipped by 8.07% to 2436000.0 in 2025, then slumped by 39.57% to 3400000.0 in 2026.
- Per Business Quant, the three latest TLPH Cash from Operations figures stand at 3400000.0 (Q1 2026), 2436000.0 (Q4 2025), and 2510000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | -3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.40 Mn |
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -2.44 Mn |
| Dec 31, 2025 | -2.44 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -2.95 Mn |
| Jun 30, 2025 | -2.95 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.94 Mn |
| Sep 30, 2024 | -2.94 Mn |
| Jun 30, 2024 | -4.61 Mn |
| Jun 30, 2024 | -4.61 Mn |
| Mar 31, 2024 | -2.88 Mn |
| Mar 31, 2024 | -2.88 Mn |
| Dec 31, 2023 | -3.95 Mn |
| Dec 31, 2023 | -3.95 Mn |